Omalizumab in Chronic Inducible Urticaria: a Real-Life Study of Efficacy, Safety, Predictors of Treatment Outcome, Time to Response and Relapse

被引：0
|
作者：
Yu, Miao [1 ]
Maurer, Marcus [2 ]
Chen, Yudi [3 ]
Zhao, Zuotao [1 ]
机构：
[1] Peking Univ, Beijing, Peoples R China
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Beijing Hosp, Beijing, Peoples R China
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
083
引用
收藏
页码：AB26 / AB26
页数：1
相关论文
共 50 条
  • [21] Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria
    Apalla, Zoe
    Sidiropoulos, Theodoros
    Kampouropoulou, Evaggelia
    Papageorgiou, Marina
    Lallas, Aimilios
    Lazaridou, Elizabeth
    Smaragdi, Maria
    Delli, Florentina
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (06) : 716 - 722
  • [22] The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data
    Salman, Andac
    Demir, Gizem
    Bekiroglu, Nural
    DERMATOLOGIC THERAPY, 2019, 32 (04)
  • [23] Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
    Garcia-Gomez, Elizabeth
    Chapman, Edgardo
    Garcia-Paba, Maria Beatriz
    Ocampo-Gomez, Jaime
    Egea-Bermejo, Eduardo
    Garavito-De Egea, Gloria
    Fang, Luis
    Sarrazola, Mauricio
    Sanchez-Caraballo, Jorge Mario
    Serrano-Reyes, Carlos
    Silva-Espinosa, Diana Lucia
    Rojas-Mejia, Dolly Vanessa
    Moreno, Sergio M.
    FRONTIERS IN ALLERGY, 2022, 3
  • [24] Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience
    Ensina, Luis Felipe
    Rodrigues Valle, Solange Oliveira
    Juliani, Ana Paula
    Galeane, Michel
    dos Santos, Rosaly Vieira
    Arruda, Luisa Karla
    Lima Melo, Janaina Michelle
    de Souza, Patricia Karla
    Serpa, Faradiba Sarquis
    de Andrade, Djanira Martins
    Franca, Alfeu Tavares
    Campos, Regis Albuquerque
    Camelo-Nunes, Ines
    Sole, Dirceu
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2016, 169 (02) : 121 - 124
  • [25] Clinical Predictors of Response to Omalizumab for Treatment of Chronic Urticaria
    Clayton, Elisabeth
    Saltoun, Carol A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB244 - AB244
  • [26] Safety and efficacy of omalizumab treatment in chronic spontaneous urticaria
    Tat, Tugba Songul
    CUKUROVA MEDICAL JOURNAL, 2018, 43 (04): : 903 - 907
  • [27] Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres
    Can, P. K.
    Salman, A.
    Hosgoren-Tekin, S.
    Kocaturk, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : E679 - E682
  • [28] Efficacy and safety of omalizumab in real-life practice in India
    Mahashur, Ashok
    Talwar, Deepak
    Kotnis, Mangala
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [29] Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study
    Salman, Andac
    Ergun, Tulin
    Maria Gimenez-Arnau, Ana
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (02) : 204 - 209
  • [30] Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria
    Yang, Liu
    Yu, Rentao
    Qian, Weilu
    Zheng, Qiu
    Xiong, Jianxia
    Chen, Shuang
    Chen, Aijun
    Chen, Jin
    Fang, Sheng
    Huang, Kun
    Cai, Tao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (07) : 643 - 655
12345